These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11442482)

  • 41. Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation.
    Yamaji K; Wang Y; Liu Y; Abeyama K; Hashiguchi T; Uchimura T; Krishna Biswas K; Iwamoto H; Maruyama I
    Thromb Res; 2005; 115(4):319-25. PubMed ID: 15668192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A direct thrombin inhibitor suppresses protein C activation and factor Va degradation in human plasma: Possible mechanisms of paradoxical enhancement of thrombin generation.
    Kamisato C; Furugohri T; Morishima Y
    Thromb Res; 2016 May; 141():77-83. PubMed ID: 26974491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.
    de Maat S; Sanrattana W; Mailer RK; Parr NMJ; Hessing M; Koetsier RM; Meijers JCM; Pasterkamp G; Renné T; Maas C
    Blood; 2019 Nov; 134(19):1658-1669. PubMed ID: 31366623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proceedings: The change of fibrin split products and plasmin-inhibitor in the newborn infant.
    Suzuki S
    Thromb Diath Haemorrh; 1975 Sep; 34(1):355. PubMed ID: 52903
    [No Abstract]   [Full Text] [Related]  

  • 47. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.
    Shlipak MG; Fried LF; Crump C; Bleyer AJ; Manolio TA; Tracy RP; Furberg CD; Psaty BM
    Circulation; 2003 Jan; 107(1):87-92. PubMed ID: 12515748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of coagulation and fibrinolysis in microsurgical reconstructions in the lower extremities.
    Olsson E; Svartling N; Asko-Seljavaara S; Lassila R
    Br J Plast Surg; 2001 Oct; 54(7):597-603. PubMed ID: 11583496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
    Stenvinkel P; Heimbürger O; Paultre F; Diczfalusy U; Wang T; Berglund L; Jogestrand T
    Kidney Int; 1999 May; 55(5):1899-911. PubMed ID: 10231453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients.
    Matsumoto K; Yano Y; Gabazza EC; Araki R; Bruno NE; Suematsu M; Akatsuka H; Katsuki A; Taguchi O; Adachi Y; Sumida Y
    Diabet Med; 2007 Dec; 24(12):1322-8. PubMed ID: 17971179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes of haemostatic parameters in patients with acute cardioembolic stroke].
    Maksimova MIu; Domashenko MA; Ionova VG; Mikhal'chenko VN; Syskina EN; Okhtova FR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):22-7. PubMed ID: 22792744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients with severe sepsis vary markedly in their ability to generate activated protein C.
    Liaw PC; Esmon CT; Kahnamoui K; Schmidt S; Kahnamoui S; Ferrell G; Beaudin S; Julian JA; Weitz JI; Crowther M; Loeb M; Cook D
    Blood; 2004 Dec; 104(13):3958-64. PubMed ID: 15319291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
    Bremme K; Ostlund E; Almqvist I; Heinonen K; Blombäck M
    Obstet Gynecol; 1992 Jul; 80(1):132-7. PubMed ID: 1534880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated protein C protects against renal ischaemia/reperfusion injury, independent of its anticoagulant properties.
    Lattenist L; Jansen MP; Teske G; Claessen N; Meijers JC; Rezaie AR; Esmon CT; Florquin S; Roelofs JJ
    Thromb Haemost; 2016 Jul; 116(1):124-33. PubMed ID: 27052416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factors influencing thrombin generation measured as thrombin-antithrombin complexes levels and using calibrated automated thrombogram in patients with advanced coronary artery disease].
    Stepień E; Plicner D; Branicka A; Stankiewicz E; Pazdan A; Sniezek-Maciejewska M; Górkiewicz I; Kapelak B; Sadowski J
    Pol Arch Med Wewn; 2007 Jul; 117(7):297-305. PubMed ID: 17966595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
    Sidelmann JJ; Bladbjerg EM; Gram J; Münster AM; Jespersen J
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):405-9. PubMed ID: 18600090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
    Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.